Greenbrook TMS Profit Margin 2020-2023 | GBNHF

Current and historical gross margin, operating margin and net profit margin for Greenbrook TMS (GBNHF) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Greenbrook TMS net profit margin as of September 30, 2023 is -83.19%.
Greenbrook TMS Annual Profit Margins
Greenbrook TMS Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.004B $0.069B
Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, principally in the United States. Greenbrook TMS Inc. is based in TORONTO.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.532B 10.00
Quest Diagnostics (DGX) United States $14.447B 14.94
DaVita (DVA) United States $11.622B 15.81
Chemed (CHE) United States $9.137B 28.75
Encompass Health (EHC) United States $8.044B 22.07
Elanco Animal Health (ELAN) United States $6.389B 14.53
Option Care Health (OPCH) United States $5.286B 20.69
RadNet (RDNT) United States $3.263B 95.30
Amedisys (AMED) United States $2.981B 21.27
LifeStance Health (LFST) United States $2.235B 0.00
Astrana Health (ASTH) United States $2.075B 26.17
Addus HomeCare (ADUS) United States $1.517B 23.26
U.S Physical Therapy (USPH) United States $1.506B 39.03
Pennant (PNTG) United States $0.626B 36.58
Aveanna Healthcare Holdings (AVAH) United States $0.437B 0.00
Atai Life Sciences (ATAI) Germany $0.310B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.030B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00